These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 20673616)

  • 1. Detection of highly pathogenic avian influenza virus infection in vaccinated chicken flocks by monitoring antibodies against non-structural protein 1 (NS1).
    Takeyama N; Minari K; Kajihara M; Isoda N; Sakamoto R; Sasaki T; Kokumai N; Takikawa N; Shiraishi R; Mase M; Hagiwara J; Kodama T; Imamura T; Sakaguchi M; Ohgitani T; Sawata A; Okamatsu M; Muramatsu M; Tsukamoto K; Lin Z; Tuchiya K; Sakoda Y; Kida H
    Vet Microbiol; 2011 Jan; 147(3-4):283-91. PubMed ID: 20673616
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnostic approach for differentiating infected from vaccinated poultry on the basis of antibodies to NS1, the nonstructural protein of influenza A virus.
    Tumpey TM; Alvarez R; Swayne DE; Suarez DL
    J Clin Microbiol; 2005 Feb; 43(2):676-83. PubMed ID: 15695663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Detection of antibodies to the nonstructural protein (NS1) of avian influenza viruses allows distinction between vaccinated and infected chickens.
    Zhao S; Jin M; Li H; Tan Y; Wang G; Zhang R; Chen H
    Avian Dis; 2005 Dec; 49(4):488-93. PubMed ID: 16404988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of infected and vaccinated animals (DIVA) using the NS1 protein of avian influenza virus.
    Avellaneda G; Mundt E; Lee CW; Jadhao S; Suarez DL
    Avian Dis; 2010 Mar; 54(1 Suppl):278-86. PubMed ID: 20521645
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Appearance of serum antibodies against the avian influenza nonstructural 1 protein in experimentally infected chickens and turkeys.
    Dundon WG; Maniero S; Toffan A; Capua I; Cattoli G
    Avian Dis; 2007 Mar; 51(1 Suppl):209-12. PubMed ID: 17494555
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of M2e ELISAs for longitudinal surveillance of commercial poultry in Indonesia vaccinated against highly pathogenic avian influenza.
    Wibowo MH; Tarigan S; Sumarningsih ; Artanto S; Indriani R; Anggoro D; Putra CP; Idris S; Untari T; Asmara W; Tabbu CR; Ignjatovic J
    J Virol Methods; 2017 Nov; 249():181-188. PubMed ID: 28843786
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protective dose of a recombinant Newcastle disease LaSota-avian influenza virus H5 vaccine against H5N2 highly pathogenic avian influenza virus and velogenic viscerotropic Newcastle disease virus in broilers with high maternal antibody levels.
    Sarfati-Mizrahi D; Lozano-Dubernard B; Soto-Priante E; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
    Avian Dis; 2010 Mar; 54(1 Suppl):239-41. PubMed ID: 20521638
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Effect of Infectious Bursal Disease Virus-Induced Immunosuppression on Vaccination Against Highly Pathogenic Avian Influenza Virus.
    Spackman E; Stephens CB; Pantin-Jackwood MJ
    Avian Dis; 2018 Mar; 62(1):36-44. PubMed ID: 29620467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recombinant paramyxovirus type 1-avian influenza-H7 virus as a vaccine for protection of chickens against influenza and Newcastle disease.
    Swayne DE; Suarez DL; Schultz-Cherry S; Tumpey TM; King DJ; Nakaya T; Palese P; Garcia-Sastre A
    Avian Dis; 2003; 47(3 Suppl):1047-50. PubMed ID: 14575108
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and evaluation of avian influenza NS1 mutant virus as a potential live and killed DIVA (differentiating between infected and vaccinated animals) vaccine for chickens.
    Brahmakshatriya VR; Lupiani B; Reddy SM
    Vaccine; 2010 Mar; 28(12):2388-96. PubMed ID: 20064474
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protection against H7N3 high pathogenicity avian influenza in chickens immunized with a recombinant fowlpox and an inactivated avian influenza vaccines.
    Bertran K; Sá E Silva M; Pantin-Jackwood MJ; Swayne DE
    Vaccine; 2013 Aug; 31(35):3572-6. PubMed ID: 23707445
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development and evaluation of an avian influenza, neuraminidase subtype 1, indirect enzyme-linked immunosorbent assay for poultry using the differentiation of infected from vaccinated animals control strategy.
    Liu Y; Mundt E; Mundt A; Sylte M; Suarez DL; Swayne DE; García M
    Avian Dis; 2010 Mar; 54(1 Suppl):613-21. PubMed ID: 20521703
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection and differentiation of infected from vaccinated animals by an inactivated recombinant Newcastle disease virus/avian influenza H5 vaccine.
    Lozano-Dubernard B; Soto-Priante E; Sarfati-Mizrahi D; Castro-Peralta F; Flores-Castro R; Loza-Rubio E; Gay-Gutiérrez M
    Avian Dis; 2010 Mar; 54(1 Suppl):242-5. PubMed ID: 20521639
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A recombinant vesicular stomatitis virus replicon vaccine protects chickens from highly pathogenic avian influenza virus (H7N1).
    Kalhoro NH; Veits J; Rautenschlein S; Zimmer G
    Vaccine; 2009 Feb; 27(8):1174-83. PubMed ID: 19135116
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of chickens against H5N1 highly pathogenic avian influenza virus infection by live vaccination with infectious laryngotracheitis virus recombinants expressing H5 hemagglutinin and N1 neuraminidase.
    Pavlova SP; Veits J; Keil GM; Mettenleiter TC; Fuchs W
    Vaccine; 2009 Jan; 27(5):773-85. PubMed ID: 19041677
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of ELISA and haemagglutination inhibition as screening tests in serosurveillance for H5/H7 avian influenza in commercial chicken flocks.
    Arnold ME; Slomka MJ; Breed AC; Hjulsager CK; Pritz-Verschuren S; Venema-Kemper S; Bouwstra RJ; Trebbien R; Zohari S; Ceeraz V; Larsen LE; Manvell RJ; Koch G; Brown IH
    Epidemiol Infect; 2018 Feb; 146(3):306-313. PubMed ID: 29325601
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Development and use of fowlpox vectored vaccines for avian influenza.
    Bublot M; Pritchard N; Swayne DE; Selleck P; Karaca K; Suarez DL; Audonnet JC; Mickle TR
    Ann N Y Acad Sci; 2006 Oct; 1081():193-201. PubMed ID: 17135511
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development of a dual-protective live attenuated vaccine against H5N1 and H9N2 avian influenza viruses by modifying the NS1 gene.
    Choi EH; Song MS; Park SJ; Pascua PN; Baek YH; Kwon HI; Kim EH; Kim S; Jang HK; Poo H; Kim CJ; Choi YK
    Arch Virol; 2015 Jul; 160(7):1729-40. PubMed ID: 25959557
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel protein microarray for the detection of avian influenza virus antibodies and simultaneous distinction of antibodies against H5 and H7 subtypes.
    Xiao Q; Bi Z; Yao L; Lei J; Yan Y; Zhou J; Yan L
    Avian Pathol; 2019 Dec; 48(6):528-536. PubMed ID: 31232095
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the M2e antibody response following highly pathogenic H5N1 avian influenza virus infection and reliability of M2e ELISA for identifying infected among vaccinated chickens.
    Tarigan S; Indriani R; Durr PA; Ignjatovic J
    Avian Pathol; 2015; 44(4):259-68. PubMed ID: 25915110
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.